Janney Montgomery Scott Starts Jazz Pharmaceuticals (JAZZ) at Neutral
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $235.36 -1.09%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 44
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 44
Join SI Premium – FREE
Janney Montgomery Scott initiated coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with a Neutral rating.
For an analyst ratings summary and ratings history on Jazz Pharmaceuticals click here. For more ratings news on Jazz Pharmaceuticals click here.
Shares of Jazz Pharmaceuticals closed at $129.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Assumes Jazz Pharmaceuticals (JAZZ) at Buy
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Seaport Global Securities Starts Jack Henry (JKHY) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
